atezolizumab based treatment | nivolumab based treatment | anti-PD-(L)1 | pembrolizumab based treatment | pembrolizumab alone | pembrolizumab based treatment | ||||
atezolizumab plus cometinib | atezolizumab plus SoC | nivolumab alone | nivolumab followed by ipilimumab | pembrolizumab alone | pembrolizumab (10mg/kg) | pembrolizumab (10mg/kg) 2 weeks | pembrolizumab (2mg/kg) | pembrolizumab plus SoC |